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The CD14 receptor is expressed on the surfaces of monocytes, macrophages, and, to a lesser extent, of activated granulocytes 
and B lymphocytes (mCD14). It also exists in soluble form in the serum (sCD14), in which it binds microbial compounds 
and indoor allergens. The objectives of this study were to see whether serum sCD14 concentrations could be used as a 
marker of atopic disorders and to estimate the effects of environmental factors (tobacco smoke exposure, childhood 
residence in urban or rural areas, and having a pet) on sCD14 and IgE values. Mass fraction of sCD14 and total IgE were 
determined in the sera of atopic (N=53) and non-atopic (N=35) participants using the standard enzyme-linked 
immunosorbent assay. Exposure to pets and environmental tobacco smoke was estimated based on the International Study 
of Asthma and Allergies in Childhood questionnaire (ISAAC). Median sCD14 concentration was significantly lower in 
atopic than in non-atopic girls (3.49 vs. 3.83 μg mL-1; p<0.010). The number of smokers at home positively correlated 
with the sCD14 level in atopics, and urban atopics had significantly lower sCD14 levels than rural atopics (3.47 vs. 
3.92 μg mL-1, p=0.028). Median total IgE concentration was significantly lower in atopic pet owners than in atopics with 
no pets (161 vs. 252 kIU L-1; p=0.021). In conclusion, while sex and environmental factors might be involved in sCD14 
expression, particularly in atopics, we found no correlation between sCD14 and total IgE concentrations. The usefulness 
of sCD14 as a marker of atopic disorders should be investigated further, particularly in relation to the severity of allergic 
disorders.
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The incidence of atopic disorders such as asthma, 
allergic rhinoconjunctivitis, and atopic eczema has 
increased over the past two decades in many countries 
including Croatia (1). Atopy is a complex genetic disease 
that results from the interplay between gene variants and 
environmental influences (2). The level of specific IgE in 
serum is a good marker of sensitisation but not of clinically 
symptomatic allergy, and new markers of atopic diseases 
have been investigated (3). One such potential marker is 
the cluster of differentiation 14 (CD14), a multifunctional 
receptor on the macrophages, monocytes, and dendritic 
cells that binds lipopolysaccharides (LPS) and other 
bacterial wall compounds, fungal wall components 
(β-glucan, mannans), and indoor allergens (dust mite and 
cockroach allergens) (4-7). In serum it takes soluble form 
(sCD14), and its concentrations have been associated with 
serum IgE and asthma (8). The CD14-LPS complex plays 
a functional role in the maturation of the Th1-type response, 
suppressing the Th-2 type response, which may result in 
weakened IgE response and atopic phenotype (8). As sCD14 
levels seem to vary with age, sex, and genetic variants (9), 
its clinical relevance as a possible marker of atopic diseases 
is still not clear. Recent studies in children and adults 
reported apparently contradictory results; some have 
associated lower serum sCD14 with atopy (10) or 
sensitisation to house dust mites (6), and some reported 
increased sCD14 levels in various allergic diseases such as 
allergic alveolitis and atopic dermatitis (11-14). These 
contradicting effects of sCD14 can be explained by the fact 
that higher sCD14 levels in asthmatic patients are secondary 
to allergic inflammation. Thus, Kusunoki et al. (15) have 
proposed that CD14 can have a dual effect on atopy; it 
inhibits IgE production before allergic inflammation and 
stimulates IgE after its onset.
As environmental factors such as pets and tobacco 
smoke exposure are associated with the development of 
atopy in children (2, 16), and the relationship between 
sCD14 levels and environmental factors has been poorly 
investigated in atopic patients, understanding this 
relationship may be important for identifying the 
mechanisms that regulate IgE production.
Therefore, the aim of our study was to: (i) determine 
serum sCD14 concentrations in atopic and non-atopics 
adolescents, (ii) investigate the association between sCD14 
concentrations and environmental characteristics (childhood 
rural or urban residence, tobacco smoke exposure, pet 
keeping), and (iii) see if values sCD14 concentrations 
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The study included 88 adolescents (53 atopic and 35 
non-atopic) with median age of 19 years (range 18-19 
years). The participants were selected from a database 
containing data on 440 students (a highly homogenous 
population), who had been recruited from the University 
of Zagreb (Croatia) to participate in a larger study 
investigating the influence of various genetic and 
environmental factors on allergic respiratory diseases (17). 
We excluded adolescents with an acute infectious disease 
and those currently under antibiotic treatment. A modified 
International Study of Asthma and Allergies in Childhood 
(ISAAC) questionnaire (18) was completed by a physician 
for each participant to determine the presence of respiratory 
and skin atopic symptoms in the previous year and to take 
family history of allergies. It included questions on the 
symptoms of asthma (wheezing), rhinitis (runny nose, itchy 
nose, blocked nose, sneezing), and dermatitis (skin redness, 
itching, vesicles, and rash) as well as questions on exposure 
to various environmental and lifestyle risk factors (rural-
urban life in the childhood, smoking status, environmental 
tobacco smoke exposure, and having a pet). Respiratory 
atopic symptoms were defined as the presence of wheezing 
and/or at least two of the above mentioned rhinitis 
symptoms and positive skin prick test (SPT) on at least one 
standard inhalatory allergen. Atopic skin symptoms were 
defined as the presence of at least two of the above 
mentioned skin symptoms and positive SPT. The 
participants were categorised according to the smoking 
status as never smokers, ex-smokers (if they ceased to 
smoke at least one year before the study), and current 
smokers. Since the number of ex-smokers was very low 
(three participants), only two groups were defined for 
statistical analysis: non-smokers (comprising never smokers 
and ex-smokers) and smokers (current smokers). 
Environmental tobacco smoke exposure (passive smoke 
exposure) was assessed according to the number of smokers 
at home.
The study was designed in accordance with the Helsinki 
Declaration and approved by the Ethics Committee of the 
Institute for Medical Research and Occupational Health, 
Zagreb. Each participant was informed about the study 
protocol and signed a consent form. The participants were 
matched according to (in order of priority): 1) sex, 2) 
childhood urban/rural residence, 3) number of smokers at 
home, and 4) smoking. The smoking status was considered 
as the least relevant matching factor due to a relatively short 
period of smoking (median 3 years) in the participating 
adolescents. Even though we aimed at the 1:1 ratio between 
non-atopic and atopic participants, we had to settle for the 
1:1.5 ratio due to a limited number of participants from 
rural areas.
Methods
All participants underwent standard skin prick testing 
(SPT) with a preparation of common inhalatory allergens: 
grass pollen mixture, birch, hazel, weed (Ambrosia elatior, 
Artemisia vulgaris) pollens, house dust mites (HDM) 
(Dermatophagoides pteronyssinus, D. farinae), storage mite 
Lepidoglyphus destructor, moulds (Cladosporium 
herbarum, Alternaria alternata), and cat and dog dander 
(all from Allergopharma, Reinbeck, Germany). SPT 
included testing with positive control solution of histamine 
(10 mg mL-1) and negative buffer control solution 
(Allergopharma, Reinbeck, Germany). Skin reaction (weal) 
was evaluated after 15 min. Wheals with mean diameter 
(D+d)/2 (where “D” is the largest diameter and “d” is 
perpendicular diameter at midpoint of D) larger than 
negative control by more than 3 mm were considered 
positive. Atopy was defined as positive SPT to at least one 
of the tested allergens.
Blood samples were taken in sterile Vacutainer® tubes 
between 8 and 10 a.m. after an overnight fast and allowed 
to clot for one hour at room temperature. They were 
centrifuged at 1800 g for 10 min and stored in pyrogen-free 
polyethylene tubes at -20 °C until further analysis.
The concentration of sCD14 was determined with a 
commercial Enzo Life Science kit (Farmingdale, NY, USA; 
Cat No. ALX-850-302) using the solid-phase sandwich 
enzyme-linked immunosorbent assay (ELISA) according 
to the manufacturer’s instructions. Briefly, serum samples 
were diluted with phosphate buffer saline with Tween 20 
(PBS-T) at a ratio 1:200. Coated microtitre plates were 
incubated with diluted serum samples, standards (3.12-
50.0 ng mL-1), and reference serum and shaken for one hour 
at room temperature. After three washes, detecting antibody 
was added and the plates incubated in the shaker for another 
hour at room temperature. After washing, the substrate 
(TMB, 3,3’,5,5’-tetramethylbenzidine) was added to all 
wells and incubated at room temperature for 13±1 min 
without shaking, and the reaction was quenched by adding 
the stopping solution. Recombinant human CD14 was used 
as reference standard. The optical absorbance of each well 
was read at 450 nm using a plate reader (IASON, Graz, 
Austria). The sCD14 concentrations were calculated using 
linear regression analysis and were expressed in μg mL-1. 
All serum samples were measured in triplicate. The limit 
of detection (LOD) was 0.701 μg mL-1 and intra- and inter-
assay imprecisions (expressed as coefficients of variation) 
for sCD14 were 2.8 % and 6.4 %, respectively. The 
analytical inaccuracy shown as bias was 2.7 %. Lipemic 
and haemolysed serums were not included in sCD14 
measurements (as per manufacturer’s instructions). Total 
IgE concentration was determined using ELISA with a 
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commercial kit (Adaltis, Guidonia Montecelio Italy). The 
optical absorbance was read at 450 nm using a plate reader 
(IASON, Graz, Austria). Total IgE concentrations were 
calculated using linear regression analysis, and the results 
are expressed in kIU L-1.
Statistical analysis
For statistical analysis we used Stata/SE 11.2 for 
Windows (StataCorp LP, College Station, TX, USA). 
Differences between groups were analysed with Pearson’s 
chi-square test (or Fisher’s exact test if any expected cell 
frequency in contingency table was ≤5) for categorical 
variables and with Mann-Whitney U test for non-normally 
distributed continuous variables (age, smoking index, serum 
sCD14, and total IgE). Respiratory and skin symptoms were 
analysed in atopic subjects only, because only a few non-
atopics had them and their symptoms most probably had 
different mechanisms. Correlation between two variables 
was analysed using Spearman’s correlation. In atopics, we 
used sCD14 and logarithmically transformed IgE levels (to 
obtain normal distribution) as dependent variables for 
multiple linear regression analysis, and sex, childhood 
urban/rural residence, smoking status (smoker vs. non-
smoker), and number of smokers at home as predictors of 
atopy in children. Atopic symptoms were also used as 
predictors in order to analyse the relationship between 
sCD14 and IgE levels and clinical expression of atopy in 
the participants. The effect of having a pet on sCD14 and 
IgE levels was analysed using separate models in urban 
residents only, since in rural residents contact with domestic 
animals is already presumed. In these models sex, atopic 
symptoms, and smoking were used as predictors. All models 
were tested for normality and homoscedasticity of residuals 
and multicollinearity. Although sCD14 data were 
moderately skewed and could not be normalised by standard 
mathematical transformations, the analysis of residuals 
showed that the assumptions of linear regression were met. 
We considered p<0.05 as statistically significant. 
Considering the asymmetrical shape of distribution, serum 
IgE and serum sCD14 concentrations are presented as 
medians and 25th-75th interquartile ranges.
RESULTS
Characteristics of atopic and non-atopic participants are 
presented in Table 1. There were no significant differences 
in age, sex ratio, and environmental and lifestyle 
characteristics (rural vs. urban, smoking status, having a 
pet) between the two groups. As expected, atopic 
participants reported four and two times more respiratory 
and skin symptoms than non-atopics, respectively. Mother’s 
history of atopy was also nine times more prevalent in 






Male, N 17 26 0.964
Age in years (range) 19 19 0.346
Mother's history of atopy, N 1 15* 0.002*
Father's history of atopy, N
Symptoms, N 5 7 1.00
Wheezing or rhinitis symptoms** 4 25 <0.001**
Skin symptoms 4 13 0.128
Smoking status, N
Non-smokers 29 36 0.264
Ex-smokers 1 2
Smokers 5 15
Smoking index for current smokers 30 39 1.00
Number of smokers at home, N
0 14 27
1 12 13 0.533
>1 9 13
Urban-rural residence***, N
Urban from birth to now 21 31
Rural from birth to now 7 12
Moved from rural to urban 1 5 0.342
Moved from urban to rural 3 1
Pet, N 
At present 8 16 0.541
*Statistically significant difference (Pearson’s chi-square test; p<0.05); **statistically significant difference (Mann-Whitney U test; 
p<0.05); wheezing, rhinitis, or skin symptoms refer to the previous year; ***for two non-atopic and four atopic participants urban/
rural type of residence in early childhood was unknown
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atopics than in non-atopics. Father’s history of atopy did 
not differ significantly between the two groups.
We found a significantly lower sCD14 concentration in 
atopics than in non-atopics [3.55 (3.19-3.92) vs. 3.82 (3.53-
4.01) μg mL-1, p<0.049] (Table 2). Median sCD14 
concentration in female atopics was significantly lower than 
in female non-atopics (p<0.010), but male adolescents did 
not differ significantly in sCD14 levels (p=0.709) (Figure 
1a). Median IgE concentration was 12.5 times higher in 
atopics than non-atopics (Table 2). Differences were 
significant in both sexes but more pronounced in female 
adolescents (Figure 1b). We found no correlation between 
IgE and sCD14 levels in either atopics (ρ=-0.046, p=0.746) 
nor non-atopics (ρ=0.149, p=0.393). Figure 2 shows sCD14 
concentrations in atopics and non-atopics according to the 
residence in childhood (urban-rural). Urban atopics had 
significantly lower sCD14 levels [3.47 (3.18-3.83) μg mL-1] 
than rural atopics [3.92 (3.72-4.03) μg mL-1 p=0.028], which 
was confirmed by multiple linear regression controlled for 
sex, atopic symptoms, and smoking as predictors 
(coefficientrural vs urban=-0.32, 95 % CI -0.58 to -0.05, p=0.019, 
adjusted R2=0.24, Pmodel=0.005). In contrast, there were no 
significant differences in sCD14 levels between urban and 
rural non-atopics. 
Smokers and non-smokers did not significantly differ 
in sCD14 levels within the atopic and non-atopic groups 
(data not presented). However, environmental tobacco 
smoke exposure (number of smokers at home) positively 
correlated with sCD14 concentrations in the atopic group, 
in which near-significant Spearman’s correlation was found 
(ρ=0.270, p=0.051). This correlation became significant 
when we used the multiple regression model with sex, atopic 
symptoms, urban vs. rural residence, and smoking as 
predictors (coeff.=0.20, 95 % CI 0.06-0.34, p=0.007). Such 
a trend was not observed in non-atopic participants.
Owning a pet did not significantly affect sCD14 levels 
among atopics, even though we did observe a slight 
correlation (p=0.211).
In contrast, atopic pet owners had significantly lower 
IgE levels than atopics with no pets [161 (36.9-209) vs. 252 
(135-356) kIU L-1, p=0.021] (Figure 3). The result was 
confirmed by multiple linear regression, with sex, atopic 
symptoms, and smoking as predictors. IgE levels 
(logarithmically transformed) inversely correlated with pet 
keeping at home (coeff.=-1.28, 95 % CI -2.22 to -0.33, 
p=0.021, adjusted R2=0.44, Pmodel=0.001). Non-atopics 
showed no significant relationship between IgE levels and 
keeping a pet.
Total IgE levels did not significantly correlate with 
tobacco smoke exposure and urban-rural residence in either 
group (p ranging from 0.104 to 0.906).
We found no correlation between sCD14 levels and 
rhinitis or asthma-like symptoms in atopics, but 19 % lower 
sCD14 levels were found in male atopics with skin 
symptoms than in asymptomatic male atopics [3.13 (3.12-
3.19) vs. 3.88 (3.51-4.07), p=0.017].
DISCUSSION
Lower serum sCD14 levels in atopic adolescents found 
in our study corroborate reports from Sweden and Taiwan, 
which showed that atopic children had significantly lower 
serum sCD14 than non-atopic children (6, 11). In contrast, 
other studies reported higher serum sCD14 levels in allergic 
alveolitis (12), atopic dermatitis (13), and asthma (14, 15, 
20). Moreover, several authors found no differences in 
sCD14 concentrations between atopics and non-atopics (21, 
22). These inconsistencies in findings can be explained in 
several ways. Beside methodological differences between 
the studies, one reason for the inconsistencies may be the 
role of disease status on serum sCD14, because acute 
inflammation and acute atopic asthma have been associated 
with a higher production of CD14 (20, 23-25). In contrast, 
mild atopic manifestations may be associated with milder 
changes in sCD14 levels, as was observed in the our and 
several other studies (6, 11, 19). In our study, atopics 
presented no severe clinical features of atopic disease. Those 
with atopic skin symptoms had a mild increase sCD14 
levels, and those with rhinitis or asthma-like symptoms 
showed no increase. This is why we believe that the 
observed inconsistencies between earlier reports could be 
explained by the association between the acuteness of atopic 
diseases and CD14 expression (14, 23). Other reasons for 
the inconsistencies may be the influence of microbial and 
allergen load interacting with CD14 as well as the CD14 
gene polymorphisms (19, 26).
Sex and age can also affect CD14 expression (16). In 
our study, atopic girls showed significantly lower serum 
sCD14 levels than atopic boys. This is in accordance with 
the findings of LeVan et al. (19) that male subjects had 
higher sCD14 levels than female subjects. These results 
may indicate that atopy affects innate immunity differently 
Table 2 Serum concentrations of sCD14 and total IgE in the participants
Non-atopics 
(N=35) Atopics (N= 53) p-value
sCD14 (μg mL-1) 3.82 (3.53-4.01) 3.55 (3.19-3.92) 0.049*
Total IgE (kIU L-1) 15.8 (3.4-79.6) 196.8 (84.4-318.4) <0.001*
Data are shown as median and interquartile range; *statistically significant difference (Mann-Whitney U test; p<0.05)
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Figure 1 Serum sCD14 (A) and total IgE (B) concentrations in non-atopic and atopic adolescents in relation to sex. The box shows 
the median and interquartile range (25-75 %), and the whisker corresponds to 1.5 times the interquartile range
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in women and men, suppressing CD14 activity more in 
women than in men. Furthermore, atopy-related increase 
in total IgE was much more pronounced in girls than in 
boys, which may be related to genetically based sex 
differences in IgE regulatory mechanisms (27). Our results 
showed that atopic adolescents who grew up in rural 
communities had higher sCD14 levels than the atopics 
raised in urban settings (Figure 2), which confirms earlier 
reports such as the one by Lauener et al. (28). They 
suggested that CD14 and Toll-like receptor 2 (TLR 2) might 
serve as biological markers of exposure to a higher bacterial 
load, which can explain higher sCD14 in adolescents who 
grew up in a rural area. Another study (29) reported that 
higher expression of CD14 and TLR genes was related to 
protective factors (farming environments, endotoxin, 
extracellular polysaccharides) against the development of 
asthma and wheezing in children.
Air pollutants such as those contained in environmental 
tobacco smoke present a considerable health problem to 
the general population, including non-smokers (16, 30-32). 
Some studies suggest that active and passive smoking 
present the risk of IgE sensitisation and atopic conditions, 
atopic rhinitis and dermatitis in particular (32, 33). Our 
study however found no correlation between passive 
smoking and elevated IgE in either atopic or non-atopic 
adolescents, but in atopics passive smoking showed a 
borderline significant effect on sCD14 levels. This effect 
might be explained by chronic exposure to bacterial 
endotoxins in cigarette smoke and by gene-smoking 
interaction (34, 35).
Unlike some researchers (36, 37), we found no 
association between sCD14 levels and active smoking, but 
this may be owed to the young age of the participants 
(median 19 years) and short smoking period of 3 years.
Many studies have investigated the effect of pet keeping 
on the development of atopic diseases in children (2, 38). 
Interestingly, our results showed significantly lower IgE 
levels in the serum of atopic pet owners than in atopics 
without pets (Figure 3). This may have something to do 
with the so called “hygiene theory”, which says that pets 
are carriers of endotoxins, and exposure to endotoxin is 
responsible for the switch from IgE to IgG4 production, 
modified Th2 immune response, and beneficial effect of pet 
exposure against the risk of atopy (39). Several studies have 
found that having a pet may protect against the development 
of atopic diseases in childhood (2, 40, 41). However, the 
effect of pet keeping seems to depend on the type of the 
pet, exposure duration, and the genetic setup (41, 42). In 
contrast to IgE, we found no correlation between sCD14 
levels and pet exposure.
Furthermore, we found no correlation between sCD14 
and total IgE serum concentrations either in atopic or non-
atopic adolescents. This lack of association was also 
reported by other authors (10, 15). The mechanism through 
which CD14 might act in atopy is not known. Activation 
of CD14 appears to upregulate IL-4 and IL-12-dependent 
IgE production. Several studies have reported that certain 
CD14 polymorphisms may lead to a more severe allergic 
reaction, that is, a stronger IgE response (6, 9, 19, 21, 25). 
In contrast, polymorphisms of Toll-like receptors 2 and 4, 
which are LPS receptors too, were not associated with 
allergy and asthma when compared with controls (43).
This highlights the complexity of the interaction 
between innate and adaptive immune responses and 
Figure 2 Serum sCD14 concentrations in non-atopic and atopic adolescents in relation to childhood residence (rural-urban). The box 
shows the median and interquartile range (25-75 %), and the whisker corresponds to 1.5 times the interquartile range
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suggests that environmental and lifestyle factors should be 
considered if we seek to understand the role of sCD14 in 
allergic development (30). Understanding this interaction 
may improve insights into atopy and asthma pathogenesis 
and result in new preventive strategies (34).
To the best of our knowledge, this is the first study that 
has investigated associations between sCD14 levels and 
lifestyle risk factors in atopic adolescents in Croatia.
Our study has several limitations, including the small 
number of participants and the lack of quantitative 
environmental exposure data (such as urinary nicotine and 
cotinine for tobacco smoke exposure). However, the 
questionnaire data on smoking habits and environmental 
smoke have been validated previously, and we have 
assumed that reported tobacco smoke exposure adequately 
reflects lifestyle characteristics such as cigarette smoking. 
An advantage is that we studied a very homogenous group 
of adolescents, which excluded age-dependent variations 
in sCD14 levels. Furthermore, ELISA showed very good 
analytical properties (low intra and inter-assay imprecision 
and high accuracy).
CONCLUSION
We have shown that serum sCD14 in adolescents 
depends on sex and environmental factors (urban-rural 
residence and tobacco smoke exposure), but found no 
correlation between sCD14 and total IgE concentrations. 
The clinical usefulness of sCD14 as a marker of atopy 
should be investigated further in occupational settings, 
particularly those with endotoxin-rich aerosols and those 
associated with a high prevalence of allergic diseases and 
occupational asthma. Further longitudinal studies on large 
samples are needed to better understand the possible gene-
environment sCD14 interactions in the development of 
atopic diseases.
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Topivi receptor CD14 i ukupni IgE u serumu mladih atopičara odrasle dobi u ovisnosti o čimbenicima iz 
okoliša: pilot istraživanje
Receptor CD14 izražen je na površini monocita, makrofaga, te u manjoj mjeri na aktiviranim granulocitima i B limfocitima 
(mCD14). Također, CD14 postoji u topivom obliku u serumu (sCD14), koji ima važnu ulogu u vezanju nekih komponenata 
mikroorganizama i alergena unutarnjeg okoliša. Cilj je ovog istraživanja bio utvrditi mogu li se vrijednosti koncentracije 
sCD14 u serumu koristiti kao biljeg atopičnih poremećaja, te ustanoviti utjecaj čimbenika okoliša (pušenje, stanovanje 
u gradskom-ruralnom području tijekom djetinjstva te kućni ljubimci) na vrijednosti sCD14 i IgE. Koncentracija sCD14 
i ukupni IgE određeni su u serumu atopičara (N=53) i neatopičara (N=35) standardnim enzim-imunokemijskim metodama. 
Izloženost okolišnim čimbenicima (kućni ljubimci, pušenje) procijenjeni su prema Upitniku iz Međunarodne studije o 
astmi i alergiji (ISAAC). Medijan koncentracija sCD14 bio je značajno niži u atopičnih djevojaka nego u neatopičnih 
(3.49 vs. 3.83 μg mL-1; p<0.010). Koncentracija sCD14 u ispitanika atopičara bila je pozitivno povezana s brojem pušača 
u kući te značajno niža u atopičara s prebivalištem u gradu u odnosu na atopičare s prebivalištem na selu (3.47 vs. 
3.92 μg mL-1, p=0.028). Pronašli smo značajno nižu koncentraciju ukupnog IgE u atopičara koji imaju kućne ljubimce 
negoli u atopičara bez kućnog ljubimca (161 vs. 252 kIU L-1; p=0.021). Zaključno, premda spol i okolišni čimbenici utječu 
na izražajnost sCD14, osobito u atopičara, nismo pronašli korelaciju između koncentracija sCD14 i ukupnog IgE. Značenje 
određivanja sCD14 kao biljega atopičnih poremećaja trebala bi se dalje ispitivati, naročito u vezi sa stupnjem ozbiljnosti 
alergijskih poremećaja.
KLJUČNE RIJEČI: alergija; atopija; sCD 14; duhanski dim iz okoliša; imunoglobulin E; kućni ljubimci
